HIV-1 drug resistance testing. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
Simon
V A
VA
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D004279:DNA, Viral / Q000235:genetics*; D024882:Drug Resistance, Viral; D014644:Genetic Variation; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000191:economics / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D018579:Patient Selection; D010641:Phenotype; D016016:Proportional Hazards Models; D016896:Treatment Outcome; D019562:Viral Load; D014779:Virus Replication
D019380:Anti-HIV Agents; D004279:DNA, Viral